A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it expects to generate some $5 billion in sales in 2023. Read more
Tag: GSK PLC
China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day
China counted more than 10,000 fresh COVID cases on Friday sparking further restrictions on movement, but also eased some travel requirements in a move welcomed by financial markets. Beijing closed Read more
China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day
China counted more than 10,000 fresh COVID cases on Friday sparking further restrictions on movement, but also eased some travel requirements in a move welcomed by financial markets. Beijing closed Read more
GSK lifts 2022 view after third quarter sales of $8.99 billion beat forecasts
GSK PLC on Wednesday raised its guidance for the full year and posted rising sales for the third quarter that beat expectations. The British pharma major GSK, +0.87% GSK, +0.82% Read more
GSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine candidate for adults aged over 60 years met its primary endpoint. The U.K.-based maker of Read more